Microvascular damage in type 1 diabetic patients is reversed in the first year after simultaneous pancreas-kidney transplantation

American Journal of Transplantation

Volumn 13, Issue 5, 2013, Pages 1272-1281

  Khairoun, M ^a   De Koning, E J P ^a   Van Den Berg, B M ^a   Lievers, E ^a   De Boer, H C ^a   Schaapherder, A F M ^a   Mallat, M J K ^a   Rotmans, J I ^a   Van Der Boog, P J M ^a   Van Zonneveld, A J ^a   De Fijter, J W ^a   Rabelink, T J ^a   Reinders, M E J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Endothelial dysfunction; microvascular injury; simultaneous pancreas kidney transplantation; type 1 diabetes mellitus

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; HEMOGLOBIN A1C; THROMBOMODULIN;

ADULT; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BIOPSY; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MICROCIRCULATION; MIDDLE AGED; PANCREAS TRANSPLANTATION; POSTOPERATIVE PERIOD; TIME FACTORS; TREATMENT OUTCOME;

EID: 84876899179     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12182     Document Type: Article

References (49)

1. Cumbie BC, Hermayer KL,. Current concepts in targeted therapies for the pathophysiology of diabetic microvascular complications. Vasc Health Risk Manag 2007; 3: 823-832.
2. Tooke JE,. Microvasculature in diabetes. Cardiovasc Res 1996; 32: 764-771.
3. Rabelink TJ, de Boer HC, van Zonneveld AJ,. Endothelial activation and circulating markers of endothelial activation in kidney disease. Nat Rev Nephrol 2010; 6: 404-414.
4. Iwashima Y, Sato T, Watanabe K, et al. Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy. Diabetes 1990; 39: 983-988.
5. Oida K, Takai H, Maeda H, et al. Plasma thrombomodulin concentration in diabetes mellitus. Diabetes Res Clin Pract 1990; 10: 193-196.
6. Fiedler U, Augustin HG,. Angiopoietins: A link between angiogenesis and inflammation. Trends Immunol 2006; 27: 552-558.
7. Hammes HP, Lin J, Renner O, et al. Pericytes and the pathogenesis of diabetic retinopathy. Diabetes 2002; 51: 3107-3112.
8. Jukema JW, Smets YF, van der Pijl JW, et al. Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes Care 2002; 25: 906-911.
9. Smets YF, Westendorp RG, van der Pijl JW, et al. Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet 1999; 353: 1915-1919.
10. Sollinger HW, Odorico JS, Becker YT, D'Alessandro AM, Pirsch JD,. One thousand simultaneous pancreas-kidney transplants at a single center with 22-year follow-up. Ann Surg 2009; 250: 618-630.
11. Becker BN, Brazy PC, Becker YT, et al. Simultaneous pancreas-kidney transplantation reduces excess mortality in type 1 diabetic patients with end-stage renal disease. Kidney Int 2000; 57: 2129-2135.
12. Bohman SO, Tyden G, Wilczek H, et al. Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes 1985; 34: 306-308.
13. Nyumura I, Honda K, Babazono T, et al. A long-term prevention of diabetic nephropathy in a patient with type 1 diabetes after simultaneous pancreas and kidney transplantation. Clin Transplant 2009; 23 (Suppl 20): 54-57.
14. Tyden G, Bolinder J, Solders G, Brattstrom C, Tibell A, Groth CG,. Improved survival in patients with insulin-dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after combined pancreas and kidney transplantation. Transplantation 1999; 67: 645-648.
15. Wilczek HE, Jaremko G, Tyden G, Groth CG,. Evolution of diabetic nephropathy in kidney grafts. Evidence that a simultaneously transplanted pancreas exerts a protective effect. Transplantation 1995; 59: 51-57.
16. Brekke IB, Ganes T, Syrdalen P, Egge K, Dyrbekk D, Flatmark A,. Combined renal and pancreatic transplantation: Effects on advanced diabetic neuropathy and retinopathy. Life Support Syst 1985; 3 (Suppl 1): 680-684.
17. Mehra S, Tavakoli M, Kallinikos PA, et al. Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes. Diabetes Care 2007; 30: 2608-2612.
18. Navarro X, Sutherland DE, Kennedy WR,. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 1997; 42: 727-736.
19. Pearce IA, Ilango B, Sells RA, Wong D,. Stabilisation of diabetic retinopathy following simultaneous pancreas and kidney transplant. Br J Ophthalmol 2000; 84: 736-740.
20. Solders G, Wilczek H, Gunnarsson R, Tyden G, Persson A, Groth CG,. Effects of combined pancreatic and renal transplantation on diabetic neuropathy: A two-year follow-up study. Lancet 1987; 2: 1232-1235.
21. Goedhart PT, Khalilzada M, Bezemer R, Merza J, Ince C,. Sidestream Dark Field (SDF) imaging: A novel stroboscopic LED ring-based imaging modality for clinical assessment of the microcirculation. Opt Express 2007; 15: 15101-15114.
22. Djaberi R, Schuijf JD, de Koning EJ, et al. Non-invasive assessment of microcirculation by sidestream dark field imaging as a marker of coronary artery disease in diabetes. Diab Vasc Dis Res 2012. Epub ahead of print.
23. Marang-van de Mheen PJ, Nijhof HW, Khairoun M, Haasnoot A, van der Boog PJ, Baranski AG,. Pancreas-kidney transplantations with primary bladder drainage followed by enteric conversion: Graft survival and outcomes. Transplantation 2008; 85: 517-523.
24. Cremers SC, Scholten EM, Schoemaker RC, et al. A compartmental pharmacokinetic model of cyclosporin and its predictive performance after Bayesian estimation in kidney and simultaneous pancreas-kidney transplant recipients. Nephrol Dial Transplant 2003; 18: 1201-1208.
25. Scholten EM, Cremers SC, Schoemaker RC, et al. AUC-guided dosing of tacrolimus prevents progressive systemic overexposure in renal transplant recipients. Kidney Int 2005; 67: 2440-2447.
26. Rowshani AT, Scholten EM, Bemelman F, et al. No difference in degree of interstitial Sirius red-stained area in serial biopsies from area under concentration-over-time curves-guided cyclosporine versus tacrolimus-treated renal transplant recipients at one year. J Am Soc Nephrol 2006; 17: 305-312.
27. Khairoun M, Baranski AG, van der Boog PJ, Haasnoot A, Mallat MJ, Marang-van de Mheen PJ,. Urological complications and their impact on survival after kidney transplantation from deceased cardiac death donors. Transpl Int 2009; 22: 192-197.
28. Malaise J, Arbogast H, Illner WD, et al. Simultaneous pancreas-kidney transplantation: Analysis of rejection. Transplant Proc 2005; 37: 2856-2858.
29. Cheung AT, Perez RV, Chen PC,. Improvements in diabetic microangiopathy after successful simultaneous pancreas-kidney transplantation: A computer-assisted intravital microscopy study on the conjunctival microcirculation. Transplantation 1999; 68: 927-932.
30. Kuryliszyn-Moskal A, Dubicki A, Zarzycki W, Zonnenberg A, Gorska M,. Microvascular abnormalities in capillaroscopy correlate with higher serum IL-18 and sE-selectin levels in patients with type 1 diabetes complicated by microangiopathy. Folia Histochem Cytobiol 2011; 49: 104-110.
31. Bergers G, Song S,. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 2005; 7: 452-464.
32. Boone MI, Farber ME, Jovanovic-Peterson L, Peterson CM,. Increased retinal vascular tortuosity in gestational diabetes mellitus. Ophthalmology 1989; 96: 251-254.
33. Sasongko MB, Wong TY, Nguyen TT, Cheung CY, Shaw JE, Wang JJ,. Retinal vascular tortuosity in persons with diabetes and diabetic retinopathy. Diabetologia 2011; 54: 2409-2416.
34. Dobrin PB, Schwarcz TH, Baker WH,. Mechanisms of arterial and aneurysmal tortuosity. Surgery 1988; 104: 568-571.
35. Hanahan D,. Signaling vascular morphogenesis and maintenance. Science 1997; 277: 48-50.
36. Jackson ZS, Dajnowiec D, Gotlieb AI, Langille BL,. Partial off-loading of longitudinal tension induces arterial tortuosity. Arterioscler Thromb Vasc Biol 2005; 25: 957-962.
37. Kohner EM, Patel V, Rassam SM,. Role of blood flow and impaired autoregulation in the pathogenesis of diabetic retinopathy. Diabetes 1995; 44: 603-607.
38. Kristinsson JK, Gottfredsdottir MS, Stefansson E,. Retinal vessel dilatation and elongation precedes diabetic macular oedema. Br J Ophthalmol 1997; 81: 274-248.
39. Cai J, Kehoe O, Smith GM, Hykin P, Boulton ME,. The angiopoietin/Tie-2 system regulates pericyte survival and recruitment in diabetic retinopathy. Invest Ophthalmol Vis Sci 2008; 49: 2163-2171.
40. Hughes S, Gardiner T, Baxter L, Chan-Ling T,. Changes in pericytes and smooth muscle cells in the kitten model of retinopathy of prematurity: Implications for plus disease. Invest Ophthalmol Vis Sci 2007; 48: 1368-1379.
41. Meyer MF, Pfohl M, Schatz H,. Assessment of diabetic alterations of microcirculation by means of capillaroscopy and laser-Doppler anemometry. Med Klin (Munich) 2001; 96: 71-77.
42. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M,. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339: 69-75.
43. Kennedy WR, Navarro X, Goetz FC, Sutherland DE, Najarian JS,. Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 1990; 322: 1031-1037.
44. Martinenghi S, Comi G, Galardi G, Di CV, Pozza G, Secchi A,. Amelioration of nerve conduction velocity following simultaneous kidney/pancreas transplantation is due to the glycaemic control provided by the pancreas. Diabetologia 1997; 40: 1110-1112.
45. David S, John SG, Jefferies HJ, et al. Angiopoietin-2 levels predict mortality in CKD patients. Nephrol Dial Transplant 2012; 27: 1867-1872.
46. Tuo QH, Zeng H, Stinnett A, et al. Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis. Am J Physiol Heart Circ Physiol 2008; 294: H2547-H2557.
47. David S, Kumpers P, Hellpap J, et al. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation. Am J Kidney Dis 2009; 53: 770-778.
48. David S, Kumpers P, Lukasz A, et al. Circulating angiopoietin-2 levels increase with progress of chronic kidney disease. Nephrol Dial Transplant 2010; 25: 2571-2576.
49. Keven K, Elmaci S, Sengul S, et al. Soluble endothelial cell protein C receptor and thrombomodulin levels after renal transplantation. Int Urol Nephrol 2010; 42: 1093-1098.